Clinical controversies in aerosol therapy for infants and children

Respiratory Care

Volumn 60, Issue 6, 2015, Pages 894-914

  DiBlasi, Robert M ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Aerosol delivery; Inhaled drugs; Neonatal; Noninvasive ventilation; Pediatric

Indexed keywords

BRONCHODILATING AGENT; LUCINACTANT; SALBUTAMOL; AEROSOL;

AEROSOL DELIVERY; ARTIFICIAL VENTILATION; BREATHING PATTERN; BRONCHIOLITIS; BRONCHODILATATION; CHILD; DRUG DELIVERY SYSTEM; DRY POWDER INHALER; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; INHALATION; MEDICAL NEBULIZER; METERED DOSE INHALER; NEBULIZATION; NONINVASIVE VENTILATION; NOSE AIRWAY RESISTANCE; NOTE; OXYGEN NASAL CANNULA; PEAK INSPIRATORY FLOW; PEDIATRIC FACE MASK; POSITIVE END EXPIRATORY PRESSURE VENTILATOR; PRESSURE SUPPORT VENTILATION; RESPIRATORY CARE; RESPIRATORY THERAPEUTIC DEVICE; TIDAL VOLUME; TREATMENT OUTCOME; ADMINISTRATION AND DOSAGE; AEROSOL; DEVICES; EQUIPMENT DESIGN; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER; NEWBORN; PRESCHOOL CHILD; PROCEDURES;

ADMINISTRATION, INHALATION; AEROSOLS; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; INFANT; INFANT, NEWBORN; NEBULIZERS AND VAPORIZERS; RESPIRATORY THERAPY;

EID: 84944730492     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.04137     Document Type: Note

References (113)

1. Amirav I, Newhouse MT. Deposition of small particles in the developing lung. Paediatr Respir Rev 2012;13(2):73-78.
2. Xi J, Si X, Zhou Y, Kim J, Berlinski A. Growth of nasal and laryngeal airways in children: implications in breathing and inhaled aerosol dynamics. Respir Care 2014;59(2):263-273.
3. DiBlasi RM, Richardson CP, Hansen T. Pulmonary physiology of the newborn. In: Gleason A, Devasker S, editors. Avery’s diseases of the newborn, 9th edition. Philadelphia: Saunders; 2012:44-41- 44-13.
4. Amirav I, Borojeni AA, Halamish A, Newhouse MT, Golshahi L. Nasal versus oral aerosol delivery to the lungs in infants and toddlers. Pediatr Pulmonol 2015;50(3):276-283.
5. Martin RJ, Miller MJ, Siner B, DiFiore JM, Carlo WA. Effects of unilateral nasal occlusion on ventilation and pulmonary resistance in infants. J Appl Physiol 1989;66(6):2522-2526.
6. Salmon B, Wilson NM, Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child 1990; 65(4):401-403.
7. Mallol J, Rattray S, Walker G, Cook D, Robertson CF. Aerosol deposition in infants with cystic fibrosis. Pediatr Pulmonol 1996; 21(5):276-281.
8. Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD, Le Souef PN. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994;7(12):2185-2191.
9. Amirav I, Balanov I, Gorenberg M, Luder AS, Newhouse MT, Groshar D. Beta-agonist aerosol distribution in respiratory syncytial virus bronchiolitis in infants. J Nucl Med 2002;43(4):487-491.
10. Erzinger S, Schueepp KG, Brooks-Wildhaber J, Devadason SG, Wildhaber JH. Facemasks and aerosol delivery in vivo. J Aerosol Med 2007;20(Suppl 1):S78-S83; discussion S83-S84.
11. Tal A, Golan H, Grauer N, Aviram M, Albin D, Quastel MR. Deposition pattern of radiolabeled salbutamol inhaled from a metered- dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 1996;128(4):479-484.
12. Svartengren M, Svartengren K, Aghaie F, Philipson K, Camner P. Lung deposition and extremely slow inhalations of particles. Limited effect of induced airway obstruction. Exp Lung Res 1999; 25(4):353-366.
13. Newhouse MT, Hirst PH, Duddu SP, Walter YH, Tarara TE, Clark AR, Weers JG. Inhalation of a dry powder tobramycin Pulmo-Sphere formulation in healthy volunteers. Chest 2003;124(1):360-366.
14. Corcoran TE, Niven R, Verret W, Dilly S, Johnson BA. Lung deposition and pharmacokinetics of nebulized cyclosporine in lung transplant patients. J Aerosol Med Pulm Drug Deliv 2014;27(3): 178-184.
15. Corcoran TE, Devadason SG, Kuehl PJ. Introduction: aerosol delivery of orally inhaled agents. J Aerosol Med Pulm Drug Deliv 2012;25(Suppl 1):S3-S5.
16. Fink JB. Aerosol delivery to ventilated infant and pediatric patients. Respir Care 2004;49(6):653-665.
17. Ari A, Restrepo RD, American Association for Respirator Care. Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care 2012;57(4):613-626.
18. Myers TR. The science guiding selection of an aerosol delivery device. Respir Care 2013;58(11):1963-1973.
19. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2014;6:CD001266.
20. Hardy JG, Newman SP, Knoch M. Lung deposition from four nebulizers. Respir Med 1993;87(6):461-465.
21. Lødrup Carlsen KC, Nikander K, Carlsen KH. How much nebulized budesonide reaches infants and toddlers? Arch Dis Child 1992; 67(9):1077-1079.
22. Tiemersma S, Minocchieri S, van Lingen RA, Nelle M, Devadason SG. Vibrating membrane devices deliver aerosols more efficiently than standard devices: a study in a neonatal upper airway model. J Aerosol Med Pulm Drug Deliv 2013;26(5):280-286.
23. El Taoum KK, Xi J, Kim JW, Berlinski A. In vitro evaluation of aerosols delivered via the nasal route. Respir Care 2015 [Epub ahead of print] doi: 10.4187/respcare.03606.
24. Lin HL, Wan GH, Chen YH, Fink JB, Liu WQ, Liu KY. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child. Respir Care 2012;57(11):1894-1900.
25. Ari A, Dornelas de Andrade A, Sheard M, Al Hamad B, Fink JB. Performance comparisons of jet and mesh nebulizers using different interfaces in simulated spontaneously breathing adults and children. J Aerosol Med Pulm Drug Deliv 2014 [Epub ahead of print] doi: 10.1089/jamp.2014.1149.
26. Ditcham W, Murdzoska J, Zhang G, Roller C, von Hollen D, Nikander K, Devadason SG. Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma. J Aerosol Med Pulm Drug Deliv 2014;27(Suppl 1):S63-S75.
27. Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of _2-agonist particle size. Am J Respir Crit Care Med 2005;172(12):1497-1504.
28. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics 2001;108(2):389-394.
29. Shah SA, Berlinski AB, Rubin BK. Force-dependent static dead space of face masks used with holding chambers. Respir Care 2006; 51(2):140-144.
30. Janssens HM, Tiddens HA. Facemasks and aerosol delivery by metered dose inhaler-valved holding chamber in young children: a tight seal makes the difference. J Aerosol Med 2007;20(Suppl 1): S59-S63; discussion S63-S65.
31. Ari A, Fink JB. Effective bronchodilator resuscitation of children in the emergency room: device or interface? Respir Care 2011;56(6): 882-885.
32. Amirav I, Mansour Y, Mandelberg A, Bar-Ilan I, Newhouse MT. Redesigned face mask improves “real life” aerosol delivery for Nebuchamber. Pediatr Pulmonol 2004;37(2):172-177.
33. Turpeinen M, Nikander K, Malmberg LP, Pelkonen A. Metered dose inhaler add-on devices: is the inhaled mass of drug dependent on the size of the infant? J Aerosol Med 1999;12(3):171-176.
34. Chavez A, McCracken A, Berlinski A. Effect of face mask dead volume, respiratory rate and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol 2010;45(3):224-229.
35. Lin HL, Restrepo RD, Gardenhire DS, Rau JL. Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir Care 2007;52(8):1021-1026.
36. Smaldone GC, Berg E, Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med 2005;18(3):354-363.
37. Sangwan S, Gurses BK, Smaldone GC. Facemasks and facial deposition of aerosols. Pediatr Pulmonol 2004;37(5):447-452.
38. Mansour MM, Smaldone GC. Blow-by as potential therapy for uncooperative children: an in-vitro study. Respir Care 2012;57(12): 2004-2011.
39. Nikander K, Berg E, Smaldone GC. Jet nebulizers versus pressurized metered-dose inhalers with valved holding chambers: effects of the facemask on aerosoldelivery. J Aerosol Med 2007;20(Suppl 1):S46-S55; discussion S55-S58.
40. Amirav I, Newhouse MT, Luder A, Halamish A, Omar H, Gorenberg M. Feasibility of aerosol drug delivery to sleeping infants: a prospective observational study. BMJ Open 2014;4(3):e004124.
41. Amirav I, Balanov I, Gorenberg M, Groshar D, Luder AS. Nebulizer hood compared to mask in wheezy infants: aerosol therapy without tears! Arch Dis Child 2003;88(8):719-723.
42. Kim J, Xi J, Si X, Berlinski A, Su WC. Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model. J Aerosol Med Pulm Drug Deliv 2014;27(3):209-218.
43. Kugelman A, Amirav I, Mor F, Riskin A, Bader D. Hood versus mask nebulization in infants with evolving bronchopulmonary dysplasia in the neonatal intensive care unit. J Perinatol 2006;26(1): 31-36.
44. Amirav I, Oron A, Tal G, Cesar K, Ballin A, Houri S, et al. Aerosol delivery in respiratory syncytial virus bronchiolitis: hood or face mask? J Pediatr 2005;147(5):627-631.
45. te Pas AB, Wong C, Kamlin CO, Dawson JA, Morley CJ, Davis PG. Breathing patterns in preterm and term infants immediately after birth. Pediatr Res 2009;65(3):352-356.
46. Wise PH, Krauss AN, Waldman S, Auld PA. Flow-volume loops in newborn infants. Crit Care Med 1980;8(2):61-63.
47. Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolized drug in infants. Arch Dis Child 1999;81(2):163-165.
48. Murakami G, Igarashi T, Adachi Y, Matsuno M, Adachi Y, Sawai M, et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy 1990;64(4): 383-387.
49. Baty R. Blow-by revisited. Respir Care 2008;53(7):920-921; author reply 921-922.
50. Rubin BK. Bye-bye, blow-by. Respir Care 2007;52(8):981.
51. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulisers. Arch Dis Child 1992;67(5):586-591.
52. Restrepo RD, Dickson SK, Rau JL, Gardenhire DS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care 2006;51(1):56-61.
53. Wildhaber JH, Devadason SG, Eber E, Hayden MJ, Everard ML, Summers QA, LeSouëf PN. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax 1996;51(10): 985-988.
54. Bisgaard H, Anhøj J, Wildhaber JH. Spacer devices. In: Bisgaard H, O’Callaghan C, Smaldone GC, editors. Drug delivery to the lung. New York: Marcel Dekker; 2002:389-420.
55. Rau JL, Coppolo DP, Nagel MW, Avvakoumova VI, Doyle CC, Wiersema KJ, Mitchell JP. The importance of nonelectrostatic materials in holding chambers for delivery of hydrofluoroalkane albuterol. Respir Care 2006;51(5):503-510.
56. Coppolo DP, Mitchell JP, Nagel MW. Levalbuterol aerosol delivery with a nonelectrostatic versus a nonconducting valved holding chamber. Respir Care 2006;51(5):511-514.
57. Minai BA, Martin JE, Cohn RC. Results of a physician and respiratory therapist collaborative effort to improve long-term metered dose inhaler technique in a pediatric asthma clinic. Respir Care 2004;49(6):600-605.
58. Cotterell EM, Gazarian M, Henry RL, O’Meara MW, Wales SR. Child and parent satisfaction with the use of spacer devices in acute asthma. J Paediatr Child Health 2002;38(6):604-607.
59. Fok TF, Monkman S, Dolovich M, Gray S, Coates G, Paes B, et al. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996;21(5):301-309.
60. DiBlasi RM, Coppolo DP, Nagel MW, Doyle CC, Avvakoumova VI, Ali RS, Mitchell JP. A novel, versatile valved holding chamber for delivering inhaled medications to neonates and small children: laboratory simulation of delivery options. Respir Care 2010;55(4): 419-426.
61. Delgado A, Chou KJ, Silver EJ, Crain EF. Nebulizers vs. metered dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. Arch Pediatr Adolesc Med 2003;157(1):76-80.
62. Leversha AM, Campanella SG, Aickin RP, Asher MI. Cost and effectiveness of spacer versus nebulizer in young children with moderate to severe acute asthma. J Pediatr 2000;136(4):497-502.
63. Deerojanawong J, Manuyakorn W, Prapphal N, Harnruthakorn C, Sritippayawan S, Samransamruajkit R. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Pediatr Pulmonol 2005;39(5):466-472.
64. Osmond M, Diner B. Evidence-based emergency medicine. Nebulizers versus inhalers with spacers for acute asthma in pediatric patients. Ann Emerg Med 2004;43(3):413-415.
65. Ploin D, Chapuis FR, Stamm D, Robert J, David L, Chatelain PG, et al. High-dose albuterol by meter-dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: a double blind, randomized equivalence trial. Pediatrics 2000; 106(2 Pt 1):311-317.
66. Kerem E, Levison H, Schuh S, O’Brodovich H, Reisman J, Bentur L, Canny GJ. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993; 123(2):313-317.
67. Cates CJ, Bara A, Crilly JA, Rowe BH. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2003;3:CD000052.
68. Castro-Rodriguez JA, Rodrigo GJ. Beta-agonists through metered dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr 2004;145(2): 172-177.
69. Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013;9:CD000052.
70. Salyer JW, DiBlasi RM, Crotwell DN, Cowan CA, Carter ER. The conversion to metered-dose inhaler with valved holdingchamber to administer inhaled albuterol: a pediatric hospital experience. Respir Care 2008;53(3):338-345.
71. Krebs SE, Flood RG, Peter JR, Gerard JM. Evaluation of a highdose continuous albuterol protocol for treatment of pediatric asthma in the emergency department. Pediatr Emerg Care 2013;29(2):191-196.
72. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003;(4):CD001115.
73. Kim IK, Phrampus E, Venkataraman S, Pitetti R, Saville A, Corcoran T, et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005;116(5):1127-1133.
74. Levitt MA, Gambrioli EF, Fink JB. Comparative trial of continuous nebulization versus metered-dose inhaler in the treatment of acute bronchospasm. Ann Emerg Med 1995;26(3):273-277.
75. Bhashyam AR, Wolf MT, Marcinkowski AL, Saville A, Thomas K, Carcillo JA, Corcoran TE. Aerosol delivery through nasal cannulas: an in vitro study. J Aerosol Med Pulm Drug Deliv 2008;21(2):181-188.
76. Ari A, Harwood R, Sheard M, Dailey P, Fink JB. In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr Pulmonol 2011;46(8):795-801.
77. Kearney CN, Crotwell DN, van Well J, Gommers E, Shen S, Zheng J, et al. Influence of patient interface and gas composition on albuterol delivery in a spontaneously breathing infant and child model: a bench study (abstract). Respir Care 2014;59(10):OF30.
78. Perry SA, Kesser KC, Geller DE, Selhorst DM, Rendle JK, Hertzog JH. Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system. Pediatr Crit Care Med 2013;14(5):e250–e256.
79. Smedsaas-Löfvenberg A, Nilsson K, Moa G, Axelsson I. Nebulization of drugs in a nasal CPAP system. Acta Paediatr 1999;88(1): 89-92.
80. Sunbul FS, Fink JB, Harwood R, Sheard MM, Zimmerman RD, Ari A. Comparison of HFNC, bubble CPAP and SiPAP on aerosol delivery in neonates: an in-vitro study. Pediatr Pulmonol 2014 [Epub ahead of print] doi: 10.1002/ppul.23123.
81. Farney KD, Kuehne BT, Gibson LA, Nelin LD, Shepherd EG. In vitro evaluation of radio-labeled aerosol delivery via a variableflow infant CPAP system. Respir Care 2014;59(3):340-344.
82. Abdelrahim ME, Plant P, Chrystyn H. In-vitro characterisation of the nebulised dose during non-invasive ventilation. J Pharm Pharmacol 2010;62(8):966-972.
83. Branconnier MP, Hess DR. Albuterol delivery during noninvasive ventilation. Respir Care 2005;50(12):1649-1653.
84. White CC, Crotwell DN, Shen S, Salyer J, Yung D, Zheng J, DiBlasi RM. Bronchodilator delivery during simulated pediatric noninvasive ventilation. Respir Care 2013;58(9):1459-1466.
85. Hintz SR. Pharmacology review: bronchodilator therapy in the preterm infant. NeoReviews 2003;4(9):e245–e249.
86. Sosulski R, Abbasi S, Bhutani VK, Fox WW. Therapeutic value of terbutaline in bronchopulmonary dysplasia. Pediatr Pulmonol 1986; 2(5);269-273.
87. Gappa M, Gärtner M, Poets CF, von der Hardt H. Effects of salbutamol delivery from a metered dose inhaler versus jet nebuliser on dynamic lung mechanics in very preterm infants with chronic lung disease. Pediatr Pulmonol 1997;23(6):442-448.
88. Bindl L, Fahnenstich H, Peukert U. Aerosolized prostacyclin for pulmonary hypertension in neonates. Arch Dis Child Fetal Neonatal Ed 1994;71(3):F214–F216.
89. Yilmaz O, Kahveci H, Zeybek C, Ciftel M, Kilic O. Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension. Am J Perinatol 2014;31(4):321-326.
90. Carroll CL, Backer CL, Mavroudis C, Cook K, Goodman DM. Inhaled prostacyclin following surgical repair of congenital heart disease—a pilot study. J Card Surg 2005;20(5):436-439.
91. Lampland AL, Wolfson MR, Mazela J, Henderson C, Gregory TJ, Meyers P, et al. Aerosolized KL4 surfactant improves shortterm survival and gas exchange in spontaneously breathing newborn pigs with hydrochloric acid-induced acute lung injury. Pediatr Pulmonol 2014;49(5):482-489.
92. Diblasi RM. Clearing the mist from our eyes: bronchodilators, mechanical ventilation, new devices, locations, and what you should know about bias flow. Respir Care 2010;55(7):942-946.
93. Ballard J, Lugo RA, Salyer JW. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit. Respir Care 2002;47(1):31-38.
94. Salyer JW. Manual resuscitators: some inconvenient truths. Respir Care 2009;54(12):1638-1643.
95. Lin HL, Fink JB, Zhou Y, Cheng YS. Influence of moisture accumulation in inline spacer on delivery of aerosol using metered-dose inhaler during mechanical ventilation. Respir Care 2009;54(10):1336-1341.
96. Grigg J, Arnon S, Jones T, Clarke A, Silverman M. Delivery of therapeutic aerosols to intubated babies. Arch Dis Child 1992;67(1 Spec No):25-30.
97. Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med 2003;168(10):1205-1209.
98. Dhand R, Mercier E. Effective inhaled drug administration to mechanically ventilated patients. Expert Opin Drug Deliv 2007;4(1):47-61.
99. Ehtezazi T, Turner MA. The application of mechanical aerosol delivery systems in an in vitro model of mechanically ventilated neonates. Recent Pat Drug Deliv Formul 2013;7(3):174-183.
100. Flavin M, MacDonald M, Dolovich M, Coates G, O’Brodovich H. Aerosol delivery to the rabbit lung with an infant ventilator. Pediatr Pulmonol 1986;2(1):35-39.
101. Fok TF, Al-Essa M, Monkman S, Dolovich M, Girard L, Coates G, Kirpalani H. Pulmonary deposition of salbutamol aerosol delivered by metered dose inhaler, jet nebulizer, and ultrasonic nebulizer in mechanically ventilated rabbits. Pediatr Res 1997;42(5):721-727.
102. Cameron D, Arnot R, Clay M, Silverman M. Aerosol delivery in neonatal ventilator circuits: a rabbit lung model. Pediatr Pulmonol 1991;10(3):208-213.
103. Dubus JC, Vecellio L, De Monte M, Fink JB, Grimbert D, Montharu J, et al. Aerosol deposition in neonatal ventilation. Pediatr Res 2005;58(1):10-14.
104. Ari A, Atalay OT, Harwood R, Sheard MM, Aljamhan EA, Fink JB. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010;55(7):845-851.
105. Cooper DS, Schwartz SM, Raake JL, Beam AR, Nelson DP. Supplemental inhaled gases alter tidal volume delivery and measurement. Pediatr Crit Care Med 2005;6(2):150-153.
106. Ari A, Areabi H, Fink JB. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care 2010;55(7):837-844.
107. Berlinski A, Willis JR. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care 2013;58(7):1124-1133.
108. DiBlasi RM, Shen S, Crotwell D, Salyer J, Mahaffey T, Yung D. Iloprost drug delivery during infant mechanical ventilation: influence of nebulizer position during conventional and high frequency ventilation (abstract). Respir Care 2013;57(10):1774.
109. Parker DK, Shen S, Zhiang J, Ivy DD, Yung D, DiBlasi RM. Inhaled treprostinil using a vibrating mesh nebulizer in mechanically ventilated adult, pediatric, and infant lung models (abstract). Respir Care 2014;59(10):OF6.
110. Mazela J, Chmura K, Kulza M, Henderson C, Gregory TJ, Moskal A, et al. Aerosolized albuterol sulfate delivery under neonatal ventilatory conditions: in vitro evaluation of a novel ventilator circuit patient interface connector. J Aerosol Med Pulm Drug Deliv 2014;27(1):58-65.
111. Garner SS, Wiest DB, Bradley JW. Albuterol delivery by metereddose inhaled in a pediatric high-frequency oscillatory ventilation mode. Crit Care Med 2000;28(6):2086-2089.
112. Sood BG, Peterson J, Malian M, Galli R, Geisor-Walter M, McKinnon J, et al. Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size. Pharmacol Res 2007;56(6):531-541.
113. Sood BG, Latif Z, Shen Y, Galli RJ, Dunlap CW, Gelmini MJ, Haacke EM. Aerosol delivery during high frequency jet ventilation: an MRI evaluation. Respir Care 2012;57(11):1901-1907.